Impact of HER2-targeted PET/CT imaging in patients with breast cancer and therapeutic response monitoring.
Xin-Yu GuiXu LiangXiaoyi GuoZhi YangGuohong SongPublished in: The oncologist (2024)
HER2-targeted PET/CT imaging offers a practical, non-invasive, and quantitative approach for assessing HER2 status in breast cancer patients, facilitating the optimization and personalization of therapeutic strategies by oncologists.